Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Airway bacterial infections are a major problem in lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Increased Th2 cytokines, such as IL-13, are observed in lung diseases and may contribute to bacterial infections. How Th2 cytokines affect bacterial infection remains unknown.
MUC18
, an adhesion molecule shown to be involved in the pathogenesis of malignant melanoma, has been recently identified in airway epithelial cells of patients with COPD. We investigated
MUC18
regulation by IL-13 and the role of
MUC18
in bacterial adherence to epithelial cells. Human airway tissues, brushed bronchial epithelial cells from normal subjects and subjects with asthma, and epithelial cell lines (e.g., HEK293 cells) were used to study the regulation of
MUC18
by IL-13 and the involvement of
MUC18
in bacterial (e.g., Mycoplasma pneumoniae [Mp] and nontypeable
Haemophilus
influenzae [NTHi]) adherence to epithelial cells. Asthmatic bronchial epithelium expressed higher levels of
MUC18
than normal bronchial epithelium. IL-13 increased
MUC18
in cultured bronchial epithelial cells from normal subjects and particularly from subjects with asthma. IL-13-induced
MUC18
expression may be modulated in part through transcription factor specificity protein 1. Overexpression of human
MUC18
in HEK293 cells increased cell-associated Mp and NTHi levels. Moreover,
MUC18
was shown to directly interact with Mp and NTHi. These results for the first time show that an allergic airway milieu (e.g., IL-13) increases
MUC18
expression, which may contribute to increased bacterial infection/colonization in asthma and other lung diseases.
...
PMID:Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherence. 2123 4